Abstract
A 6-year-old boy with juvenile Paget's disease and recurrent fractures has been treated by daily intramuscular injections of 1 mg of synthetic human calcitonin for 16 months. Regression of the bony abnormalities was apparent within seven months of the start of treatment. Levels of serum alkaline phosphatase and urine hydroxyproline fell during the first four months, but have remained high ever since. We suggest that these continuing high levels reflect in part the healing of the diseased bones.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
